![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Glucosamine-Modified Mesoporous Silica-Coated Magnetic Nanoparticles: A “Raisin-Cake”-like Structure as an Efficient Theranostic Platform for Targeted Methotrexate Delivery
Fatemeh Farjadian, Zahra Faghih, Maryam Fakhimi, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2491-2491
Open Access | Times Cited: 8
Fatemeh Farjadian, Zahra Faghih, Maryam Fakhimi, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2491-2491
Open Access | Times Cited: 8
Showing 8 citing articles:
Extracellular Vesicles and Exosomes: Novel Insights and Perspectives on Lung Cancer from Early Detection to Targeted Treatment
S. Rahimian, Hossein Najafi, Baran Afzali, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 123-123
Open Access | Times Cited: 18
S. Rahimian, Hossein Najafi, Baran Afzali, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 123-123
Open Access | Times Cited: 18
Enhancing Drug Solubility, Bioavailability, and Targeted Therapeutic Applications through Magnetic Nanoparticles
Yue Zhuo, Yong‐Gang Zhao, Yun Zhang
Molecules (2024) Vol. 29, Iss. 20, pp. 4854-4854
Open Access | Times Cited: 9
Yue Zhuo, Yong‐Gang Zhao, Yun Zhang
Molecules (2024) Vol. 29, Iss. 20, pp. 4854-4854
Open Access | Times Cited: 9
Cutting-edge advancements in anticancer drug delivery and scope for theranostics using biocompatible multifunctional mesoporous silica nanoparticles
S Sarnaik, Dhananjay Bhatane, Sharon Rose Pamshong, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 94, pp. 105504-105504
Closed Access | Times Cited: 3
S Sarnaik, Dhananjay Bhatane, Sharon Rose Pamshong, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 94, pp. 105504-105504
Closed Access | Times Cited: 3
Functionalized tin-loaded mesoporous silica nanoparticles for targeted therapy of triple-negative breast cancer: Evaluation of cytogenetic toxicity
Pallavi C. Choudante, Jhansi Mamilla, Lalithya Kongari, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 94, pp. 105502-105502
Closed Access | Times Cited: 3
Pallavi C. Choudante, Jhansi Mamilla, Lalithya Kongari, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 94, pp. 105502-105502
Closed Access | Times Cited: 3
In vivo treatment of zinc phosphide poisoning by administration of mesoporous silica nanoparticles as an effective antidote agent
Fatemeh Farjadian, Reza Heidari, Soliman Mohammadi‐Samani
Heliyon (2024) Vol. 10, Iss. 8, pp. e29458-e29458
Open Access | Times Cited: 2
Fatemeh Farjadian, Reza Heidari, Soliman Mohammadi‐Samani
Heliyon (2024) Vol. 10, Iss. 8, pp. e29458-e29458
Open Access | Times Cited: 2
Nano Strategies for Artemisinin Derivatives to Enhance Reverse Efficiency of Multidrug Resistance in Breast Cancer
Xueyan Zhang, Na Li, Guoqin Zhang, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 43, pp. 3458-3466
Closed Access | Times Cited: 4
Xueyan Zhang, Na Li, Guoqin Zhang, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 43, pp. 3458-3466
Closed Access | Times Cited: 4
Theranostics: silver nanoparticles mediated drug delivery
Elham Abbasgholinejad, Mohammad Doroudian, Mahdieh Soezi, et al.
Elsevier eBooks (2024), pp. 231-252
Closed Access
Elham Abbasgholinejad, Mohammad Doroudian, Mahdieh Soezi, et al.
Elsevier eBooks (2024), pp. 231-252
Closed Access
Exosome-Based Advances in Pancreatic Cancer: The Potential of Mesenchymal Stem Cells
S. Rahimian, Kimia Mirkazemi, Armita Kamali Nejad, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 207, pp. 104594-104594
Closed Access
S. Rahimian, Kimia Mirkazemi, Armita Kamali Nejad, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 207, pp. 104594-104594
Closed Access